Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|10|1|63-75

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.10, Iss.1, 2018-01, pp. : 63-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombopoietin: tickling the HSC's fancy

By  

EMBO Molecular Medicine, Vol. 10, Iss. 1, 2018-01 ,pp. : 10-12

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selection-Mutation Dynamics of Signaling Games

By Hofbauer Josef   Huttegger Simon M.  

Games, Vol. 6, Iss. 1, 2015-01 ,pp. : 2-31

MDPI

Access to resources Recommend Favorite

Characterisation of the Cullin‐3 mutation that causes a severe form of familial hypertension and hyperkalaemia

By  

EMBO Molecular Medicine, Vol. 1757-4676, Iss. 10, 2015-10 ,pp. : 1285-1306

John Wiley & Sons Inc

Access to resources Recommend Favorite

A nonsense mutation of human XRCC4 is associated with adult‐onset progressive encephalocardiomyopathy

By  

EMBO Molecular Medicine, Vol. 7, Iss. 7, 2015-07 ,pp. : 918-929

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characterisation of the Cullin‐3 mutation that causes a severe form of familial hypertension and hyperkalaemia

By  

EMBO Molecular Medicine, Vol. 7, Iss. 10, 2015-10 ,pp. : 1285-1306

John Wiley & Sons Inc

Access to resources Recommend Favorite